Publicacións en colaboración con investigadores/as de Universidad de Valladolid (184)

2023

  1. Economic Burden of the 2020 COVID-19 Hospitalizations in Spain

    JAMA network open, Vol. 6, Núm. 1, pp. e2250960

  2. Environmental factors are associated to hospital outcomes in COVID-19 patients during lockdown and post-lockdown in 2020: A nationwide study

    Environmental Research, Vol. 229

  3. Increase in driving after cocaine use in Spain: a cross-sectional dataset analysis for 2021

    Frontiers in Public Health, Vol. 11

  4. Medication economic burden of antidepressant non-adherence in Spain

    Frontiers in Pharmacology, Vol. 14

  5. Prevalence and cost of hospitalized patients with asymptomatic COVID-19 in 2020 in Spain

    Frontiers in Public Health, Vol. 11

  6. Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 2019

    Pharmaceuticals, Vol. 16, Núm. 4

2022

  1. ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points

    Frontiers in Medicine, Vol. 9

  2. Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival

    Medicina (Lithuania), Vol. 58, Núm. 6

  3. Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality

    Critical Care, Vol. 26, Núm. 1

  4. Impact of the Economic Crisis on Endocarditis Mortality in Spain: A Nationwide Study

    International Journal of Health Services, Vol. 52, Núm. 3, pp. 383-391

  5. Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study

    Pharmaceutics, Vol. 14, Núm. 12

2021

  1. A population-based registry analysis on hospitalized covid-19 patients with previous cardiovascular disease: Clinical profile, treatment, and predictors of death

    Journal of Cardiovascular Development and Disease, Vol. 8, Núm. 12

  2. Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials

    Frontiers in Medicine, Vol. 8

  3. Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can

    Frontiers in Immunology, Vol. 12

  4. Clinical Profile, Pharmacological Treatment, and Predictors of Death Among Hospitalized COVID-19 Patients With Acute Kidney Injury: A Population-Based Registry Analysis

    Frontiers in Medicine, Vol. 8

  5. Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  6. HGF, IL-1α, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  7. Positivity to cocaine and/or benzoylecgonine in confirmation analyses for on-road tests in spain

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 10

  8. Predictive modeling of poor outcome in severe covid-19: A single-center observational study based on clinical, cytokine and laboratory profiles

    Journal of Clinical Medicine, Vol. 10, Núm. 22

  9. Trends in the use of antihistamines with reference to drivers between 2015 and 2019: A population-based registry analysis

    Fundamental and Clinical Pharmacology, Vol. 35, Núm. 6, pp. 1168-1178